Incorporating HIV Pre-Exposure Prophylaxis Care for Patients Seeking Induced Abortion and Pregnancy Loss Management
- 5 January 2022
- journal article
- research article
- Published by Elsevier in Women's Health Issues
- Vol. 32 (4) , 388-394
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (5-P30-AI-45008-18)
- Society of Family Planning (Medcines360)
- Pharmaceuticals Bayer
This publication has 33 references indexed in Scilit:
- Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in WomenNew England Journal of Medicine, 2016
- United States family planning providers' knowledge of and attitudes towards preexposure prophylaxis for HIV prevention: a national surveyContraception, 2016
- Knowledge, Attitudes, and Likelihood of Pre-Exposure Prophylaxis (PrEP) Use Among US Women at Risk of Acquiring HIVAIDS Patient Care and STDs, 2015
- Specialized Family Planning Clinics in the United States: Why Women Choose Them and Their Role in Meeting Women's Health Care NeedsWomen's Health Issues, 2012
- Integration of HIV/AIDS services with maternal, neonatal and child health, nutrition, and family planning servicesCochrane Database of Systematic Reviews, 2012
- Evaluation of the London Measure of Unplanned Pregnancy in a United States Population of WomenPLOS ONE, 2012
- Attitudes Toward Unprotected Intercourse and Risk of Pregnancy among Women Seeking AbortionWomen's Health Issues, 2012
- Development of the Perceived Risk of HIV ScaleAIDS and Behavior, 2011
- Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae genital infections in a publicly funded pregnancy termination clinic: empiric vs. indicated treatment?Contraception, 2008
- Sexual and reproductive health: a matter of life and deathThe Lancet, 2006